The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data
Caroline E Dale, Rohan Takhar, Ray Carragher, Fatemeh Torabi, Michalis Katsoulis, Stephen Duffield, Seamus Kent, View ORCID ProfileTanja Mueller, Amanj Kurdi, Stuart McTaggart, View ORCID ProfileHoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Dan Harris, Alex Handy, Mehrdad Alizadeh Mizani, View ORCID ProfileChris Tomlinson, Mark Ashworth, View ORCID ProfileSpiros Denaxas, View ORCID ProfileAmitava Banerjee, Jonathan Sterne, Kate Lovibond, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Naveed Sattar, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Reecha Sofat on behalf of the CVD-COVID-UK Consortium
doi: https://doi.org/10.1101/2021.12.31.21268587
Caroline E Dale
1Institute of Health Informatics Research, University College London
Rohan Takhar
1Institute of Health Informatics Research, University College London
Ray Carragher
2Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde
Fatemeh Torabi
3Swansea University
Michalis Katsoulis
1Institute of Health Informatics Research, University College London
Stephen Duffield
4The National Institute for Health and Care Excellence
Seamus Kent
4The National Institute for Health and Care Excellence
Tanja Mueller
5University of Strathclyde
Amanj Kurdi
2Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde
Stuart McTaggart
6Public Health Scotland
Hoda Abbasizanjani
3Swansea University
Sam Hollings
7NHS Digital, Leeds
Andrew Scourfield
8UCLH NHS Foundation Trust
Ronan Lyons
3Swansea University
Rowena Griffiths
3Swansea University
Jane Lyons
3Swansea University
Gareth Davies
3Swansea University
Dan Harris
3Swansea University
Alex Handy
1Institute of Health Informatics Research, University College London
Mehrdad Alizadeh Mizani
1Institute of Health Informatics Research, University College London
Chris Tomlinson
1Institute of Health Informatics Research, University College London
Mark Ashworth
9King’s College London
Spiros Denaxas
1Institute of Health Informatics Research, University College London
Amitava Banerjee
1Institute of Health Informatics Research, University College London
Jonathan Sterne
10University of Bristol
Kate Lovibond
11Royal College of Physicians
Paul Brown
7NHS Digital, Leeds
Ian Bullard
7NHS Digital, Leeds
Rouven Priedon
12British Heart Foundation Data Science Centre, Health Data Research UK, London
Mamas A Mamas
13Keele University
Ann Slee
14NHSX
Paula Lorgelly
15Department of Applied Health Research, University College London
Munir Pirmohamed
16University of Liverpool
Kamlesh Khunti
17University of Leicester
Naveed Sattar
18University of Glasgow
Andrew Morris
19Health Data Research UK
Cathie Sudlow
12British Heart Foundation Data Science Centre, Health Data Research UK, London
Ashley Akbari
3Swansea University
Marion Bennie
5University of Strathclyde
Reecha Sofat
1Institute of Health Informatics Research, University College London
16University of Liverpool
Article usage
Posted January 07, 2022.
The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data
Caroline E Dale, Rohan Takhar, Ray Carragher, Fatemeh Torabi, Michalis Katsoulis, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Dan Harris, Alex Handy, Mehrdad Alizadeh Mizani, Chris Tomlinson, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan Sterne, Kate Lovibond, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Naveed Sattar, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Reecha Sofat
medRxiv 2021.12.31.21268587; doi: https://doi.org/10.1101/2021.12.31.21268587
The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data
Caroline E Dale, Rohan Takhar, Ray Carragher, Fatemeh Torabi, Michalis Katsoulis, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Dan Harris, Alex Handy, Mehrdad Alizadeh Mizani, Chris Tomlinson, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan Sterne, Kate Lovibond, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Naveed Sattar, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Reecha Sofat
medRxiv 2021.12.31.21268587; doi: https://doi.org/10.1101/2021.12.31.21268587
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2908)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12679)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4534)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2897)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4302)
- Nursing (233)
- Nutrition (631)
- Oncology (2250)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6884)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (207)
- Urology (178)